Biosynthetic origin and functional significance of murine platelet factor V
- 15 October 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (8) , 2851-2855
- https://doi.org/10.1182/blood-2003-04-1224
Abstract
Factor V (FV), a central regulatory protein in hemostasis, is distributed into distinct plasma and platelet compartments. Although platelet FV is highly concentrated within the platelet α-granule, previous analysis of human bone marrow and liver transplant recipients has demonstrated that platelet FV in these individuals originates entirely from the uptake of plasma FV. In order to examine further the biosynthetic origins of the platelet and plasma FV pools, we performed bone marrow transplantations of Fv-null (Fv–/–) fetal liver cells (FLCs) into wild-type mice. Fractionation of whole blood from control mice demonstrated that approximately 14% of total blood FV activity is platelet-associated. Mice that received transplants of Fv-null FLCs displayed a high degree of engraftment and appeared grossly normal, with no evidence for spontaneous hemorrhage. Although total FV levels in Fv-null FLC recipients were only mildly decreased, the FV activity within the platelet compartment was reduced to less than 1% of that in normal mice. We conclude that the murine platelet FV compartment is derived exclusively from primary biosynthesis within cells of marrow origin, presumably megakaryocytes, and that an intact platelet FV pool is not required for protection from spontaneous hemorrhage or bleeding following minor trauma.Keywords
This publication has 36 references indexed in Scilit:
- The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasisBlood, 2003
- Factor V and Thrombotic DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor VNature, 1996
- Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line.Journal of Clinical Investigation, 1993
- Vascular smooth muscle cells synthesize, secrete and express coagulation factor VBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1988
- Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.Journal of Clinical Investigation, 1986
- Isolation and study of an acquired inhibitor of human coagulation factor V.Journal of Clinical Investigation, 1986
- Biosynthesis of factor V in isolated guinea pig megakaryocytes.Journal of Clinical Investigation, 1985
- Patients with Congenital Factor V Deficiency have Decreased Factor Xa Binding Sites on their PlateletsJournal of Clinical Investigation, 1978
- The Hemostatic Effect of Normal Platelets in Hemophilia and factor V DeficiencyActa Medica Scandinavica, 1961